In Partnership with

Arise Health logoThe Paak logoThe Paak logoThe Paak logo

A Path to a Cure

Families impacted by ALS comprise the community most likely to support research necessary to cure the disease.  Most people don’t live with ALS long enough to advocate for themselves, and today it is not possible to survive ALS.  So it is up to those with a connection to this disease to invest time and resources in pursuit of a cure.  

There are many organizations that support research, patient care and advocacy in the ALS community.  Families of newly diagnosed people most often prioritize caring for their loved one over an immediate and active role supporting an ALS organization.  This makes sense, the disease can be all consuming not only for the patient, but also the caregiving family.  

Path to a Cure is an event to ensure those with a connection to the disease understand where progress is being made and where help is needed.  This balance of sharing good news and a call for more resources is the best formula for engaging people with the connection and means to help.  The event itself will bring thought leaders from ALS research, patient care, advocacy and the family experience together to discuss the state of ALS.  This discussion is not targeted at an academic or clinical audience, though both will be in attendance.  Our audience will walk away with a clear understanding of what is happening and where they can make a difference.

Speakers

Richard S. Bedlack Jr., MD, PhD, MS

Neurologist
Dr. Bedlack is currently Stewart, Hughes, and Wendt Distinguished Professor of ALS at Duke and Director of the Duke ALS Program.

Cynthia L. Bodkin, MD

Sleep Medicine, Neurology
Dr. Bodkin specializes in sleep disorders with IU Health and has expertise in neuromuscular diseases and sleep disorders, with a specific interest in respiratory insufficiency in neurological patients, amyotrophic lateral sclerosis (ALS), myasthenia gravis, circadian rhythm disorders, and REM sleep behavior disorder (RBD).

Angi Micheels

IU Health ALS Clinic Coordinator
Trained as a physical therapist, Angi helps patients, care teams and loved ones navigate care at IU Health’s Neuroscience Center in downtown Indianapolis. She said her role within the multidisciplinary clinic is especially valuable for those diagnosed with neurological disorders.

Carol Hamilton

Vice President of Development, ALS TDI
As head of Government Affairs, Carol worked closely with Congress, the Department of Defense, and the Veterans Administration, resulting in $6M in contracts for the Institute, and the establishment of the ALS Research Program at the Department of Defense, sending tens of millions of dollars into the ALS research ecosphere.

Andrea Goodman

CEO, I AM ALS
Andrea Goodman is the CEO of I AM ALS, a groundbreaking national movement to end ALS through patient voice and urgency, public awareness, and policy & systems change. She is a national public health leader with two decades of experience building and scaling innovative healthcare solutions that improve outcomes for families and communities.

Larry Falivena

Chair, ALS Association Board
Larry Falivena is a member of the Board of Trustees for the ALS Association and a retired Salesforce account executive with 18 years of experience serving the nonprofit sector. Diagnosed with ALS in 2017, Larry is committed to making a meaningful impact in the fight against the disease while prioritizing time with his family.

Details

Friday, March 20, 2026
8:30am – 11:00am
High Alpha
830 Massachusetts Ave
Indianapolis, IN 46204
Reserve your seat
For alternative payment options check here or contact Marianne Bartos

Join the fight against ALS

Please consider donating to support the cause.